About Clarametyx Biosciences

Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.

Repeat Founder
Company Highlights
Year Founded

2020

icon-altEmployees

18

Location (HQ)

USA

Since Last Funding

8 months

Monthly Website Visitors

3.3K

icon-altTotal Investment Amt

$59M

Last Funding Round

Series A

icon-altYoY Headcount Growth

28.37%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Health Care

Biotechnology

Biotechnology Research

Medical